Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis - Wikidata - awgldk - TriplyDB

Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis

Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis

http://www.wikidata.org/entity/Q36101138

about

Metabolism of kidney cancer: from the lab to clinical practice Novel drugs that target the metabolic reprogramming in renal cell cancer An Optimized Method of Metabolite Extraction from Formalin-Fixed Paraffin-Embedded Tissue for GC/MS Analysis Bladder cancer biomarker discovery using global metabolomic profiling of urine The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.Assessment of data pre-processing methods for LC-MS/MS-based metabolomics of uterine cervix cancer.Analysis of multi-source metabolomic data using joint and individual variation explained (JIVE).Effects of imputation on correlation: implications for analysis of mass spectrometry data from multiple biological matrices.Small molecule metabolite biomarker candidates in urine from mice exposed to formaldehyde Addition of DHA Synergistically Enhances the Efficacy of Regorafenib for Kidney Cancer Therapy.Inhibition of PPARα induces cell cycle arrest and apoptosis, and synergizes with glycolysis inhibition in kidney cancer cells.Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry.PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis.Metabolomics changes in a rat model of obstructive jaundice: mapping to metabolism of amino acids, carbohydrates and lipids as well as oxidative stress.The cpk model of recessive PKD shows glutamine dependence associated with the production of the oncometabolite 2-hydroxyglutarate.Multivariate two-part statistics for analysis of correlated mass spectrometry data from multiple biological specimens.Comparative Circadian Metabolomics Reveal Differential Effects of Nutritional Challenge in the Serum and Liver Effects of Arsenite Exposure during Fetal Development on Energy Metabolism and Susceptibility to Diet-Induced Fatty Liver Disease in Male Mice.Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers Applications of metabolomics for kidney disease research: from biomarkers to therapeutic targets.Learning subgroup-specific regulatory interactions and regulator independence with PARADIGM.Metabolomics reveals that tumor xenografts induce liver dysfunction.In-Depth Characterization and Validation of Human Urine Metabolomes Reveal Novel Metabolic Signatures of Lower Urinary Tract Symptoms.Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma.Mealtime, temporal, and daily variability of the human urinary and plasma metabolomes in a tightly controlled environment.Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer.Potential biofluid markers and treatment targets for renal cell carcinoma.Metabolomics for tumor marker discovery and identification based on chromatography-mass spectrometry.Analytical protocols based on LC-MS, GC-MS and CE-MS for nontargeted metabolomics of biological tissues.Novel methodologies in analysis of small molecule biomarkers and living cells.Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems.High-Throughput Indirect Quantitation of 13C Enriched Metabolites Using 1H NMR.Short overview on metabolomics approach to study pathophysiology of oxidative stress in cancer.[Medical perspectives of metabolomics: the example of renal carcinoma].Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging.The crucial role of multiomic approach in cancer research and clinically relevant outcomes.Metabolomics and Metabolic Reprogramming in Kidney Cancer.Translating Metabolic Reprogramming into New Targets for Kidney Cancer

P2860

Q24600512-69ED4903-C6FD-45AD-B59F-3A549E235EE4 Q26740187-0837E7B5-ABEF-4591-ADE9-6BA71D993508 Q27320823-9420E032-4CF1-4ACD-BDC2-E5F5E78331CE Q28542873-BAE9D120-0F07-436C-8968-FCA77431AE9E Q30277177-E8C632E4-74F0-44CD-BD18-D263E96D7593 Q30597785-A3B41116-4DFA-413B-8B95-1011B44385C1 Q30954181-0A2C3350-837A-4041-AC0F-DA72D5445955 Q31047935-A4899560-CF8E-4914-B6D4-7F409D42C8EA Q34358979-2E5D9114-6031-4E23-B5FD-0010302957EA Q34515993-B59EEA7D-7AF3-4448-90C2-D2ABF2F82FBC Q34948760-B1B00D2E-4DA2-4BF7-8FFE-831338667C29 Q35171220-8881353E-B803-4622-B9A4-2F3B9112457E Q35671904-53C89A1E-24DF-4565-B500-0E4AC24C9219 Q35752074-2A7D7D56-0F7C-4EAA-A52F-48D7BD0AE772 Q35883201-E480CE47-5FB8-4E7A-9DAC-CCDFB1513309 Q36066391-7D80C536-CC63-4EA5-A3E5-35FE3E75C2E6 Q36122695-8110BF25-0E27-4426-BA67-0B927FF844B2 Q36548377-C7065722-AA03-4FBC-8D58-48EF37063B05 Q36567359-26BDF7FD-33C0-4C71-A2F6-7B64BFAF748D Q36832498-68E2307F-573E-4A05-A1C1-BF7B5BABF96B Q36906135-C9B8DBCB-4C00-4294-8C77-6A71608EE4EB Q36960648-D519E4BF-18B0-4712-BC03-39BBCF8EDB73 Q37072851-FA89EA73-E404-4049-85EC-E09FBA60AA2E Q37159996-D4D36D56-828E-4335-BBB6-E81591AB5A51 Q37421650-B7EAA1F1-A4DB-417D-9A6F-917BA7B5F566 Q37514271-3FA6C5CC-B977-43C5-8AC9-8353FF3A9520 Q37687020-245DE4DD-2DF5-41FC-B28B-478802666CE1 Q38094918-03FEF62A-C931-4B48-A065-3197F3E29A05 Q38103592-8EE33EF5-E814-4AB4-A2D9-192723D9F0E3 Q38235440-8CDBC1D4-BF27-4C85-8A76-B0A0393A32D2 Q38239586-23770E95-D92C-4EB5-92CA-E18EE0158249 Q38709622-FAEDE6ED-F1A4-4549-99E2-7CED764D7921 Q38740625-35CB457F-98C3-4F1E-A1EA-97939B38F6B5 Q41607194-57AEA6E6-86A6-4DDC-8035-C67BD09D1D44 Q45384812-7AF85D6E-7CC1-4D56-902E-CE4DCD401E66 Q46105764-6CD9E204-93B4-4E9D-8337-08A2E06C49F7 Q52363678-DF1C3BB0-A295-435E-A8BF-E851666D4E45 Q52618376-2362CDB5-CA44-459C-990E-902A55121373 Q58585088-0E539797-0241-49DA-A33E-5A204ACB07F6

P2860

Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis

http://www.wikidata.org/entity/Q36101138

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis

@ast

Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis

@en

type

label

Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis

@ast

Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis

@en

prefLabel

Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis

@ast

Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis

@en

P1433

Q36101138-C24AA2C2-D52F-40D6-8E54-EDCA6484ECDE

P1476

Q36101138-D3B4A433-95BC-4033-BB4D-ED5538DA5051

P2093

Q36101138-7E294984-3444-4F0A-8514-4B768C13E5B6

Q36101138-90448F70-37A0-4389-9A8B-B911E317A7B4

Q36101138-91DB5FFB-DCB9-4150-A99D-06C008980AF8

Q36101138-C40FC75F-0FC4-4360-BA70-69CAD955669D

Q36101138-CF1613B5-A5E5-4150-B069-A65C85040A85

Q36101138-D60106C6-DCEE-492A-BF3E-326554B822B5

Q36101138-E402511D-C482-4053-B585-3401035B27BF

Q36101138-FBD49DAA-8F9D-47CA-ADA7-1EDD0683275E

P2860

Q36101138-0089AD13-3DF0-459B-8EBE-E0DD4DD447C6

Q36101138-0092E1AB-F01C-480A-84CA-4426B8B18BA3

Q36101138-09E2EDED-2EEE-4101-A98C-50D0DE1AAC3C

Q36101138-0B9DBF39-41ED-4F88-AC80-D4886821408A

Q36101138-2073CF75-53F4-42BC-ADF2-13C8ADEB6E1D

Q36101138-244EB137-16B7-4254-BA9C-EB0CF661F096

Q36101138-2E90B33F-CB64-49B9-8414-C044257B9C67

Q36101138-302B940C-3D0C-4681-AC04-ED6F03C53F9C

Q36101138-425CFA30-8020-46B7-ABA3-A3C8ECB56964

Q36101138-44E189BA-0243-4526-81C8-B958A405DDF4

P304

Q36101138-3CB5963E-D334-4D65-896D-D52E07E7A2F0

P31

Q36101138-2E5BA2C5-DE3C-4D73-9E73-E4A633591889

P356

Q36101138-0DE44CFA-3155-4ADD-9AF5-542C42B70C12

P407

Q36101138-F4C880CF-54D3-406F-9B1A-64D42D8A027D

P433

Q36101138-7E26D1A5-8F9D-4B5E-88A5-01A606E150B0

P478

Q36101138-8369BAA7-94FA-4A59-8134-B1C33554EA42

P50

Q36101138-E6A1CCAE-DF57-4B12-A186-701EA6CC4C49

P577

Q36101138-9041C9AE-F7E3-4CC0-AC02-CA576B3CE309

P698

Q36101138-5EA0DE42-AFB3-4251-B4F9-72FFC41F0CC6

P921

Q36101138-5D68E966-87CF-40D3-AE31-964D90A1C389

P932

Q36101138-54AAD527-7BDE-4E99-9CD7-118187B9BD70

P356

0008-5472.CAN-11-3105

P1433

Cancer Research

P1476

Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis

@en

P2093

Christopher Evans

http://www.w3.org/2001/XMLSchema#string

Danny C Alexander

http://www.w3.org/2001/XMLSchema#string

Joy Yang

http://www.w3.org/2001/XMLSchema#string

Kyoungmi Kim

http://www.w3.org/2001/XMLSchema#string

Michael V Osier

http://www.w3.org/2001/XMLSchema#string

Omran Abu Aboud

http://www.w3.org/2001/XMLSchema#string

Robert H Weiss

http://www.w3.org/2001/XMLSchema#string

Sheila Ganti

http://www.w3.org/2001/XMLSchema#string

P2860

Pathway analysis of kidney cancer using proteomics and metabolic profiling

Prevention of allogeneic fetal rejection by tryptophan catabolism

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

Oxidative stress as a major culprit in kidney disease in diabetes

The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells

Metabolomics in the study of kidney diseases

Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems.

PPARalpha: energy combustion, hypolipidemia, inflammation and cancer

P304

3471-3479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-11-3105

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

Sandra L. Taylor

P577

2012-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22628425

http://www.w3.org/2001/XMLSchema#string

P921

P932

3399039

http://www.w3.org/2001/XMLSchema#string